Drug General Information
Drug ID
D09IYM
Former ID
DIB002324
Drug Name
AT13148
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [523886]
Company
Astex pharmaceuticals
Target and Pathway
Target(s) Rho associated protein kinase Target Info Modulator
References
Ref 523886ClinicalTrials.gov (NCT01585701) Phase I Study of AT13148, a Novel AGC Kinase Inhibitor. U.S. National Institutes of Health.